학술논문
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET-EVER trial
Document Type
Article
Author
Source
In: European Journal of Haematology . (European Journal of Haematology, August 2024, 113(2):163-171)
Subject
Language
English
ISSN
16000609
09024441
09024441